Sort
40,608 grants matching “prostate cancer”
Forms of prostate specific antigen and hk2 in cancer
$477,115Scripps Research Institute · M01 · FY2004 · RR
Defining bone ecosystem effects on metastatic prostate cancer evolution and treatment response using an integrated mathematical modeling approach
$477,037Conor C Lynch · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2023 · CA
Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort
$476,842Mia Hashibe · University Of Utah · R01 · FY2022 · CA
Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort
$476,842Mia Hashibe · University Of Utah · R01 · FY2023 · CA
Cancer Recurrence: Detection in Administrative Data, Incidence, and Costs
$476,825Michael James Hassett · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Integrin-mediated mechanisms of prostate cancer progression
$476,796Lucia R Languino · Thomas Jefferson University · R01 · FY2020 · CA
Molecular Epidemiology of Fatal Prostate Cancer
$476,732Sheila A Weinmann · Kaiser Foundation Research Institute · R01 · FY2006 · CA
HPV genomic structure in cervical cancer radiation response and recurrence detection
$476,719Jin Zhang · Washington University · R37 · FY2024 · CA
Nanoscintillator-based X-ray sensitizers to enable efficient NSCLC treatment with X-ray irradiation
$476,715Jin Xie · University Of Georgia · R01 · FY2018 · EB
TempO-Seq Profiling of RNA Epitranscriptomic Modifications
$476,709Bruce E. Seligmann · Biospyder Technologies, Inc. · R44 · FY2021 · HG
Implementation of evidence-based cancer early detection in Black churches
$476,695Cheryl L Holt · Univ Of Maryland, College Park · R01 · FY2012 · CA
SOUTHWEST ONCOLOGY GROUP CA-13612
$476,677University Of Arizona · U10 · FY2003 · CA
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges
$476,578Biplab Dasgupta · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · NS
Image Biomarker Development for TreatmentEfficacy of Prostate Cancer to the Bone
$476,542Brian D. Ross · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
MICROFLUIDIC DIAGNOSTICS FOR MONITORING OF BRAF INHIBITOR RESISTANCE IN MELANOMA
$476,399Hsian-Rong Tseng · University Of California Los Angeles · P01 · FY2017 · CA
MICROFLUIDIC DIAGNOSTICS FOR MONITORING OF BRAF INHIBITOR RESISTANCE IN MELANOMA
$476,399Hsian-Rong Tseng · University Of California Los Angeles · P01 · FY2016 · CA
MICROFLUIDIC DIAGNOSTICS FOR MONITORING OF BRAF INHIBITOR RESISTANCE IN MELANOMA
$476,399Hsian-Rong Tseng · University Of California Los Angeles · P01 · FY2015 · CA
Trans-urethral ultrasound for prostate cancer therapy
$476,391Mayo Clinic · R33 · FY2005 · CA
Development of an Optimal MRI Platform for Prostate Investigations at 7 Tesla
$476,312Gregory John Metzger · University Of Minnesota · R01 · FY2014 · CA
Project 3: Targeting SK2/S1P Signaling for the Regulation of c-Myc and Tumor Suppression
$476,309Carolyn D Britten · Medical University Of South Carolina · P01 · FY2020 · CA
Clinical validation of the HD-CTC fluid biopsy in early detection of lung cancer.
$476,289Peter Kuhn · Scripps Research Institute, The · R33 · FY2013 · CA
INCREASING ACCESS TO CLINICAL AND EDUCATIONAL STUDIES
$476,184Thomas Jefferson University · U01 · FY2004 · CA
Prognostic and Predictive Digital Tissue Image Assay for Prostate Cancer
$476,165Anant Madabhushi · Emory University · R01 · FY2024 · CA
Clinical Protocol and Data Management
$475,992Susanne M Arnold · University Of Kentucky · P30 · FY2025 · CA
Genetic Epidemiology of Prostate Cancer
$475,868Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA